Evidence map›Paper›PMID 25146662›Full record

ReviewJournal of feline medicine and surgery2014

Pharmacological appetite stimulation: rational choices in the inappetent cat.

Wendy Agnew, Rachel Korman

Open access · greenAbstract readReview
In one paragraph

Review in Journal of feline medicine and surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 46 citations in OpenAlex.

  1. Mirtazapine revisited: new therapeutic perspectives and formulation advances.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Feline Aortic Thromboembolism: Recent advances and future prospects.Journal of feline medicine and surgery · 2024
    Review
  7. Review
  8. Article
  9. Article
  10. Retrospective evaluation of maropitant and perioperative factors affecting postoperative appetite in cats.The Canadian veterinary journal = La revue veterinaire canadienne · 2021
    Article
  11. Amino Acids in the Nutrition, Metabolism, and Health of Domestic Cats.Advances in experimental medicine and biology · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Hepatic lipidosis: Clinical review drawn from collective effort.Journal of feline medicine and surgery · 2018
    Review
  17. Review
  18. Article
  19. Update in feline therapeutics: clinical use of 10 emerging therapies.Journal of feline medicine and surgery · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Wendy AgnewVeterinary Specialist Services, Cnr Lexington and Logan Roads, Underwood, Queensland 4119, Australia wagnew@vss.net.au.
Rachel KormanVeterinary Specialist Services, Cnr Lexington and Logan Roads, Underwood, Queensland 4119, Australia.
Logan Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

practical relevanceInappetence is a commonly encountered problem in feline medicine. Primary goals in managing the inappetent or anorectic cat are to diagnose and treat the underlying disease and reinstate adequate nutrition. RATIONALE: As cats are intolerant of prolonged periods of inadequate nutritional intake, especially given their propensity to develop hepatic lipidosis, their increased requirements for amino acids, and inability to slow their rate of gluconeogenesis, symptomatic therapy and nutritional support is often required during diagnostic investigations. CLINICAL CHALLENGES: Most cats presenting with reduced food intake will be suffering from an underlying systemic disease, and so the mechanism of action, pharmacokinetics and contraindications of appetite-stimulating medications will need to be considered in each case to ensure rational use of these agents. Pharmacological appetite stimulation should never replace monitoring and ensuring adequate caloric intake, and may not be appropriate in some cases, such as critically ill or severely malnourished patients. EVIDENCE BASE: While there are no medications approved specifically for the treatment of anorexia in cats, some drugs have proven efficacious in the clinical field. Although several agents have been used historically for appetite stimulation, due to potential side effects and/or lack of efficacy or predictability only cyproheptadine and mirtazapine can currently be recommended for use.

Indexed as

AnimalsAnorexiaAppetiteAppetite StimulantsCat DiseasesCatsContraindicationsEnergy IntakeFatty LiverNutritional StatusNutritional SupportAppetite Stimulants

Identifiers

PMID25146662
PMCPMC11185246
OpenAlexW2156155016

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.